EBOS Group (EBO NZ): Strong Industry Positioning and Acquisitions to Drive Growth
EBOS is an attractive bet on Australasian healthcare space, due to enhanced visibility of its accretive acquisition of LifeHealthcare and continued...
430 Views
EBOS Group: 1H22 Result — Patient Discharged; NEUTRAL
EBOS Group1H22 Result — Patient Discharged; NEUTRAL NEUTRAL EBOS Group (EBO) reported a strong 1H22 result in line with our expectations but ahead...
993 Views
EBOS Group (EBO): 1H22 Result – Initial Impressions
EBOS Group (EBO)1H22 Result – Initial Impressions EBOS Group (EBO) reported a solid 1H22 result in line with our expectations and ahead of...
973 Views
EBOS Group: 1H22 Preview — Keep the Ball Rolling
EBOS Group1H22 Preview — Keep the Ball Rolling OUTPERFORM Following a buoyant four months trading update in December we expect minimal surprises...
1k Views
Aussie Pharma (API AU): Scheme Booklet Out. Meeting On The 17 March
Trading super at a gross/annualised spread of 0.3%/2.8%. However, if you are a low-rate payer, who can reclaim the franking credits, there's may...
467 Views